COVID-19 vaccines have saved more than 2 million lives in four years. This record makes them one of humanity’s greatest medical achievements. But what if these vaccines also improved survival for cancer patients? New research suggests that may be possible.
Preclinical results suggest that COVID-19 mRNA vaccines may enhance cancer treatment. Researchers found that these vaccines can improve outcomes for patients receiving a form of immunotherapy. The study linked mRNA COVID-19 vaccines to better survival in cancer patients. These results indicate potential new uses for the vaccine beyond infection prevention.





